2028년까지 유럽 안구 약물 전달 시장 예측 – 기술(이식형 안구 약물 전달 시스템, 미립자 약물 전달 시스템, 나노입자 약물 전달 시스템 등), 제형 유형(리포솜 및 나노입자, 솔루션, 유제, 현탁제, 연고제), 질병 유형(녹내장, 당뇨병성 망막증, 안구건조증, 황반변성, 백내장, 당뇨병성 황반부종 등), 최종 사용자(병원, 안과, 외래수술센터)

시장 소개

유럽의 안구 약물 전달 시장은 독일, 영국, 프랑스, 이탈리아, 스페인 및 기타 유럽 지역으로 분류됩니다. 그리고 독일은 시장에서 가장 큰 점유율을 차지했습니다. 독일의 노인 인구의 광범위한 증가는 독일 내 안구 약물 전달 시장의 채택 증가에 대한 수익성 있는 기회를 나타냅니다. Aging Readiness & Competitiveness Initiative에 따르면 독일의 65세 이상 인구는 2050년까지 41% 증가하여 2,400만 명에 달할 것으로 예상되며 이는 전체 인구의 거의 3분의 1을 차지합니다. 또한 눈 질환을 앓고 있는 환자의 수가 많아 시장 성장을 주도하고 있습니다. European Vision Institute EEIG에 따르면 독일에서는 약 30,000명이 유전성 망막 질환을 앓고 있었습니다. 디지털화 증가와 소형 모바일 기기의 광범위한 사용으로 인해 어린 나이에 시력 장애가 발생하여 콘택트 렌즈 판매가 뒷받침되었습니다. 게다가 의료기기에 대한 기술적 지원도 탄탄하다. 이 나라에는 정교한 의료기기 개발에 전념하는 여러 회사가 있습니다. 또한, 국내 시장 참가자의 존재는 시장에서 제품 인지도와 제품 도달 범위를 높일 가능성이 높습니다. Novaliq은 독일의 안과 제약 회사로 안약 전달을 위한 최초의 무수분 기술을 개발하고 있습니다. 노발리크는 안구건조증 치료에 사용되는 기술 개발에 주력하고 있습니다. 이 회사의 제품은 국소 안구 약물 전달을 위한 독자적인 무수 기술인 EyeSol에 중점을 두고 있습니다.

유럽 지역은 코로나19 확산으로 큰 타격을 입었고 대부분의 국가가 폐쇄되었습니다. 정기 의료 서비스가 취소되고, 환자들에게 코로나19 감염 위험을 최소화하기 위해 병원 방문을 자제하도록 권고해 의료 서비스 제공과 환자 진료에 심각한 차질을 빚었습니다. 안과학은 영국에서 매년 약 750만 건의 외래 진료 예약과 500,000건 이상의 수술 절차를 수행하는 가장 바쁘고 외래 환자 중심 전문 분야 중 하나입니다. 폐쇄로 인해 수천 건의 안과 방문 및 수술이 취소되었습니다. 이는 잠재적으로 환자의 시력에 영구적이고 심각한 해를 끼칠 수 있습니다. 또한 최근 설문조사에 따르면 – ‘COVID-19 팬데믹 봉쇄가 영국에서 안과 질환을 앓고 있는 사람들에게 미치는 심리사회적 영향’ 안과 질환이 있는 대중을 대상으로 실시된 이번 연구에서는 봉쇄 조치가 시각 장애 환자에게 미치는 부정적인 심리사회적 영향을 강조했으며, 약 50%의 환자가 검토나 치료 지연으로 인한 시력 상실에 대한 두려움을 나타냈습니다.

시장 개요 및 역학

유럽의 안구 약물 전달 시장은 2021년 49억 6,764만 달러에서 2028년까지 79억 2,115만 달러로 성장할 것으로 예상됩니다. 시장은 2021년부터 2028년까지 연평균 성장률(CAGR) 6.9%로 성장할 것으로 예상됩니다. 백내장, 녹내장, 노인성 황반변성, 당뇨병성 망막증, 해결되지 않은 굴절 이상은 실명 또는 저시력의 주요 원인 중 하나입니다. 대부분의 인구는 일생 동안 눈 장애를 겪었거나 앓았습니다. 2021년 2월에 발표된 세계보건기구(WHO) 보고서 \"실명 및 시력 장애\"에 따르면 전 세계적으로 약 22억 명의 사람들이 근거리 또는 원거리 시력 장애를 겪고 있습니다. 또한 시력 상실 또는 저시력의 주요 원인은 백내장(9,400만 건)과 교정되지 않은 굴절 이상(8,840만 건)인 것으로 추정되었습니다. 또한 시력 상실의 다른 일반적인 원인으로는 녹내장(770만 명), 각막 혼탁(420만 명), 당뇨병성 망막증(390만 명), 트라코마(200만 명) 등이 있습니다. 2017년 왕립 국립 시각 장애인 연구소(Royal National Institute of Blind People)에 따르면 영국에는 약 350,000명이 시각 장애인으로 등록되어 있습니다. 약 173,735명이 중증 시각 장애인으로 등록되었습니다. 176,125명이 시각 장애인으로 등록되었습니다. 따라서 안구 질환의 확산이 안구 약물 전달 시장을 주도하고 있습니다.

주요 시장 부문

유럽 안구 약물 배달 시장은 기술, 제제 유형, 질병 유형, 최종 사용자를 기준으로 분류됩니다. 기술을 기준으로 2021년 이식형 안구 약물 전달 시스템 부문이 가장 높은 점유율을 차지했습니다. 제제 유형을 기준으로 2021년 솔루션 부문이 가장 높은 점유율을 차지했습니다. 질병 유형을 기준으로 2021년 백내장 부문이 가장 높은 점유율을 차지했습니다. 기준 2021년 최종 사용자 병원 부문이 가장 높은 점유율을 차지했습니다.

주요 소스 및 회사 목록

몇 가지 주요 1차 및 회사 유럽의 안구 약물 전달 시장에 대한 이 보고서를 준비하기 위해 참조된 보조 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서 및 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사 AbbVie Inc.; Bausch Health Companies Inc.; 노바티스 AG; Clearside Biomedical, Inc.; 엔비시아 치료제; GRAYBUG VISION, INC 기타

구매 이유 보고서

유럽 안과 약물 전달 시장의 성장, 규모, 주요 플레이어 및 부문을 식별하여 초보 수준 연구 수행 시간을 절약하고 줄입니다.
주요 사항 기업이 비즈니스 전략을 재조정하도록 지원하기 위한 비즈니스 우선순위
주요 조사 결과 및 권장 사항은 유럽 안과 약물 전달 시장의 중요한 진보적 산업 동향을 강조함으로써 가치 사슬 전반에 걸쳐 플레이어가 효과적인 장기 전략을 개발할 수 있도록 합니다.
실질적인 성장을 제공하는 선진국 및 신흥 시장을 활용하여 사업 확장 계획 개발/수정
안구 약물 전달 시장을 주도하는 요인과 함께 유럽 시장 동향 및 전망을 심층적으로 조사합니다. 이를 방해하는 요소
클라이언트 제품, 세분화, 가격 책정 및 유통과 관련하여 상업적 이익을 뒷받침하는 전략을 이해하여 의사 결정 프로세스를 향상시킵니다

유럽 안구 약물 전달 시장 세분화

유럽 안약 전달 시장 – 기술별

이식형 안구 약물 전달 시스템
미립자 약물 전달 시스템
나노입자 약물전달 시스템
기타

< 범위>유럽 안구 약물 전달 시장 – 제형 유형별

솔루션
연고
현탁액
에멀젼
리포솜 및 나노입자

< p>유럽 안구 약물 전달 시장 – 질병 유형별

유럽 안구 약물 전달 시장 – 최종 사용자별

병원
안과
외래 수술 센터

유럽 안구 약물 전달 시장 – 국가별

유럽 안구 약물 전달 시장 – 언급된 회사

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Ocular Drug Delivery Market – By Technology

1.3.2 Europe Ocular Drug Delivery Market – By Formulation Type

1.3.3 Europe Ocular Drug Delivery Market – By Disease Type

1.3.4 Europe Ocular Drug Delivery Market – By End User

1.3.5 Europe Ocular Drug Delivery Market – By Country

2. Europe Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Ocular Drug Delivery Market – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. Europe Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Drawbacks Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Raising Awareness About Vision Care

5.4 Future Trends

5.4.1 Emergence of Innovative Products

5.5 Impact analysis

6. Europe Ocular Drug Delivery – Market Analysis

6.1 Europe Ocular Drug Delivery Market Revenue Forecast and Analysis

7. Europe Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Europe Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. Europe Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.2 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.1.3 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.1.4 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.1.5 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.2.3 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.2.4 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.2.5 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.2 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.3.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.3.4 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.3.5 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.2 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.4.3 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.4.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.4.5 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.2 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.5.3 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.5.4 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.5.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.6 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.1 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.2 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.6.3 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.6.4 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.6.5 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

12. Impact Of COVID-19 Pandemic on Europe Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GRAYBUG VISION, INC.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Clearside Biomedical, Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 2. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 3. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 4. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 5. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 6. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 7. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 8. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 9. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 11. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 12. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 13. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 14. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 15. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 16. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 17. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 19. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 20. Spain Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 21. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 22. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 23. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 24. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 25. Organic Developments Done By Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. Europe Ocular Drug Delivery Market Segmentation

Figure 2. Europe Ocular Drug Delivery Market Segmentation, By Country

Figure 3. Europe Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe Ocular Drug Delivery Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. Europe Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. Europe: Ocular Drug Delivery Market Revenue Overview, by Country, 2021 (US$ MILLION)

Figure 34. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

Figure 35. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe ocular drug delivery market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in Europe ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample